Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Sep. 26, 2015	Sep. 27, 2014
Cash flows from operating activities
Net income	$ 367,491	$ 394,706
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	87,717	63,062
Equity compensation expense	25,864	21,579
Deferred income taxes	(853)	(5,402)
Amortization of deferred rent	1,729	3,146
Loss on disposal of fixed assets	1,492	1,762
Amortization of deferred financing costs	373	374
Tax benefits on exercise of share options	(9,104)	(29,653)
Foreign currency (gains) losses	(687)	3,745
Loss (income) earned on joint venture	907	(311)
Net income attributable to noncontrolling interest	(318)	0
Change in assets and liabilities:
Receivables, net	14,506	(38,551)
Inventories	(180,020)	(201,045)
Prepaid expenses and other current assets	2,454	(65,369)
Other assets	1,992	(2,664)
Accounts payable	58,669	42,107
Accrued expenses and other current liabilities	10,472	(3,280)
Other long-term liabilities	10,182	14,647
Net cash provided by operating activities	392,866	198,853
Cash flows from investing activities
Capital expenditures	(193,451)	(157,403)
Purchase of intangible assets	(9,291)	(12,060)
Cash received, net of cash consideration paid to obtain controlling interest in MK Panama	1,104	0
Investments in joint venture	(907)	(2,940)
Net cash used in investing activities	(202,545)	(172,403)
Cash flows from financing activities
Repurchase of treasury shares	(751,094)	(1,037)
Tax benefits on exercise of share options	9,104	29,653
Exercise of employee share options	6,006	8,143
Net cash (used in) provided by financing activities	(735,984)	36,759
Effect of exchange rate changes on cash and cash equivalents	(1,718)	(5,422)
Net (decrease) increase in cash and cash equivalents	(547,381)	57,787
Beginning of period	978,922	971,194
End of period	431,541	1,028,981
Supplemental disclosures of cash flow information
Cash paid for interest	381	341
Cash paid for income taxes	133,741	240,686
Supplemental disclosure of non-cash investing and financing activities
Accrued capital expenditures	$ 28,229	$ 31,044